Dr. Elham Nasri, MD

Dr. Nasri practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Nasri's NPI, 1649658626, was assigned on May 11, 2015. Dr. Nasri graduated from Isfahan University of Medical Sciences in 2009. Dr. Nasri holds Florida license ME144250.

Dr. Nasri's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Nasri's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nasri practices. Vendor and product names are available with a free account.

Anatomic pathology and clinical pathology is Dr. Nasri's primary specialty in the NPI Registry, under taxonomy code 207ZP0102X. Dr. Nasri is board certified in pathology - anatomic/pathology - clinical by the American Board of Pathology. Dmand AI has Dr. Nasri's licenses on file in 3 states: Florida, Ohio and Pennsylvania.

CMS data shows 1,038 Medicare services from Dr. Nasri across 10 procedure codes in 2024, for 258 Medicare patients. Medicare paid $29,924 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 258 Medicare patients who saw Dr. Nasri in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have arthritis, and 75% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nasri's median patient age at 71, with 46% women.

In 2024, Dr. Nasri wrote 18 Medicare Part D claims. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $6,760 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Nasri for performance year 2024, reported through an alternative payment model (APM). Dr. Nasri accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 17 papers to Dr. Nasri, published from 2022 to 2025. 2023 was the busiest year, with 6. The most frequent topics are Cyclin-Dependent Kinase Inhibitor p16, Biomarkers, Tumor and Bone Neoplasms. Dr. Nasri has published most often in BMJ Case Rep. Dr. Nasri's most frequent co-authors are Michael Martin Feely, DO, Ali Zarezadeh, MD and Christopher P. Evans, MD.

CMS Open Payments shows 2 general payments to Dr. Nasri from 2 drug and device companies from 2022 to 2023. Food and beverage make up the largest share, 100% of the total. Roche Diagnostics Corporation paid the most, $87.

Dr. Nasri graduated from Isfahan University of Medical Sciences in 2009.

Dr. Nasri is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.